TRIMEPRAZINE FOR USE IN TREATING TRIGEMINAL NEURALGIA AND FOR REDUCING PAIN RELATED THERETO
The present disclosure relates to trimeprazine for use in methods of treating trigeminal neuralgia and pain related thereto, by administering to a patient in need thereof a therapeutically effective amount of trimeprazine. The methods may include reducing a patient's pain as determined by patie...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | MANDERS, Ernest K COLLINS, Mark Anthony David |
| description | The present disclosure relates to trimeprazine for use in methods of treating trigeminal neuralgia and pain related thereto, by administering to a patient in need thereof a therapeutically effective amount of trimeprazine. The methods may include reducing a patient's pain as determined by patient-reported or clinician-delivered outcome assessments.
La présente divulgation concerne du triméprazine destiné à être utilisé dans des procédés de traitement de la névralgie du trijumeau et de la douleur associée à celle-ci, par administration à un patient qui en a besoin d'une quantité thérapeutiquement efficace de triméprazine. Les procédés peuvent comprendre la réduction de la douleur d'un patient telle que déterminée par des évaluations de résultat rapportées par le patient ou délivrées par un clinicien. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2023215277A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2023215277A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2023215277A13</originalsourceid><addsrcrecordid>eNqNy8EKgkAQxnEvHaJ6h4HOQa6E58Ed1wFdZZolqINIbKcowd6fLHqATt__8PuWyUWFG-oEz-wJylYgHAnYgwqhsndzsKOGPdbgKQjWjhHQ2y8WsqH4qA7nj1CNSha0IiFt18niNtynuPntKtmWpEW1i-Ozj9M4XOMjvvpTa_YmM-nB5Dmm2X_qDUsdMuY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>TRIMEPRAZINE FOR USE IN TREATING TRIGEMINAL NEURALGIA AND FOR REDUCING PAIN RELATED THERETO</title><source>esp@cenet</source><creator>MANDERS, Ernest K ; COLLINS, Mark Anthony David</creator><creatorcontrib>MANDERS, Ernest K ; COLLINS, Mark Anthony David</creatorcontrib><description>The present disclosure relates to trimeprazine for use in methods of treating trigeminal neuralgia and pain related thereto, by administering to a patient in need thereof a therapeutically effective amount of trimeprazine. The methods may include reducing a patient's pain as determined by patient-reported or clinician-delivered outcome assessments.
La présente divulgation concerne du triméprazine destiné à être utilisé dans des procédés de traitement de la névralgie du trijumeau et de la douleur associée à celle-ci, par administration à un patient qui en a besoin d'une quantité thérapeutiquement efficace de triméprazine. Les procédés peuvent comprendre la réduction de la douleur d'un patient telle que déterminée par des évaluations de résultat rapportées par le patient ou délivrées par un clinicien.</description><language>eng ; fre</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231109&DB=EPODOC&CC=WO&NR=2023215277A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76419</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231109&DB=EPODOC&CC=WO&NR=2023215277A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MANDERS, Ernest K</creatorcontrib><creatorcontrib>COLLINS, Mark Anthony David</creatorcontrib><title>TRIMEPRAZINE FOR USE IN TREATING TRIGEMINAL NEURALGIA AND FOR REDUCING PAIN RELATED THERETO</title><description>The present disclosure relates to trimeprazine for use in methods of treating trigeminal neuralgia and pain related thereto, by administering to a patient in need thereof a therapeutically effective amount of trimeprazine. The methods may include reducing a patient's pain as determined by patient-reported or clinician-delivered outcome assessments.
La présente divulgation concerne du triméprazine destiné à être utilisé dans des procédés de traitement de la névralgie du trijumeau et de la douleur associée à celle-ci, par administration à un patient qui en a besoin d'une quantité thérapeutiquement efficace de triméprazine. Les procédés peuvent comprendre la réduction de la douleur d'un patient telle que déterminée par des évaluations de résultat rapportées par le patient ou délivrées par un clinicien.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNy8EKgkAQxnEvHaJ6h4HOQa6E58Ed1wFdZZolqINIbKcowd6fLHqATt__8PuWyUWFG-oEz-wJylYgHAnYgwqhsndzsKOGPdbgKQjWjhHQ2y8WsqH4qA7nj1CNSha0IiFt18niNtynuPntKtmWpEW1i-Ozj9M4XOMjvvpTa_YmM-nB5Dmm2X_qDUsdMuY</recordid><startdate>20231109</startdate><enddate>20231109</enddate><creator>MANDERS, Ernest K</creator><creator>COLLINS, Mark Anthony David</creator><scope>EVB</scope></search><sort><creationdate>20231109</creationdate><title>TRIMEPRAZINE FOR USE IN TREATING TRIGEMINAL NEURALGIA AND FOR REDUCING PAIN RELATED THERETO</title><author>MANDERS, Ernest K ; COLLINS, Mark Anthony David</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2023215277A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2023</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>MANDERS, Ernest K</creatorcontrib><creatorcontrib>COLLINS, Mark Anthony David</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MANDERS, Ernest K</au><au>COLLINS, Mark Anthony David</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>TRIMEPRAZINE FOR USE IN TREATING TRIGEMINAL NEURALGIA AND FOR REDUCING PAIN RELATED THERETO</title><date>2023-11-09</date><risdate>2023</risdate><abstract>The present disclosure relates to trimeprazine for use in methods of treating trigeminal neuralgia and pain related thereto, by administering to a patient in need thereof a therapeutically effective amount of trimeprazine. The methods may include reducing a patient's pain as determined by patient-reported or clinician-delivered outcome assessments.
La présente divulgation concerne du triméprazine destiné à être utilisé dans des procédés de traitement de la névralgie du trijumeau et de la douleur associée à celle-ci, par administration à un patient qui en a besoin d'une quantité thérapeutiquement efficace de triméprazine. Les procédés peuvent comprendre la réduction de la douleur d'un patient telle que déterminée par des évaluations de résultat rapportées par le patient ou délivrées par un clinicien.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_WO2023215277A1 |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | TRIMEPRAZINE FOR USE IN TREATING TRIGEMINAL NEURALGIA AND FOR REDUCING PAIN RELATED THERETO |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T18%3A47%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MANDERS,%20Ernest%20K&rft.date=2023-11-09&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2023215277A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |